Brief: Galecto Reports Operating & Financial Results Year Ended Dec 31, 2022
March 9 (Reuters) - Galecto Inc GLTO.O :
* GALECTO REPORTS OPERATING AND FINANCIAL RESULTS FOR THE
YEAR
ENDED DECEMBER 31, 2022
* GALECTO - ANTICIPATES CASH, CASH EQUIVALENTS AND
INVESTMENTS
WILL BE SUFFICIENT TO FUND OPERATING EXPENSES AND CAPITAL
REQUIREMENTS INTO H2 OF 2024
Source text for Eikon: ID:nGNX819JPd
Further company coverage: GLTO.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Damora Therapeutics
See all newsUS RESEARCH ROUNDUP-Chevron, Exxon Mobil, GoDaddy
U.S. RESEARCH ROUNDUP-Blackstone, Hartford Insurance, Zevra Therapeutics
U.S. RESEARCH ROUNDUP- Cisco, DTE Energy, Marvell Technology
Brief: Damora Therapeutics Reports First Quarter 2026 Financial Results
Brief: Damora Therapeutics: Lori Firmani To Cease Serving As CFO Effective May 1, 2026 - SEC Filing